Muse plays the fiddle-watching share price burn...
No -
Muse plays the fiddle-watching share price burn...
No - it isnt exactly like that but the cavalier attitude towards share price and that it can all be solved through MRVB and/or day trading in alignment with MRVB is rather hollow for long term investors who arent glued to a trading screen all day.
while i like the "confidence" in putting out an aggressive PPS target, it generally isnt a good idea and less one can directly influence the market to increase the chances of that happening. not only have they put it out there, they have reiterated it several times. yet - they still have not provided specifics on how they are going to make that happen by EOY. $0.01 remains a very, very lofty target both in terms in % gain but also in terms of fundamentals when the company only has booked revenues of $109K and that still remains in AR.
so - how (or becoming more important now due to time aspect - when) are they going to buy enough shares in the shortening amount of time to make this happen? when will buying commence and how much cash do they expect to put to a buyback before EOY? if they disrupt the supply/demand balance in conjunction with a substantial PR (and 8K) showing some guaranteed revenues (or as much as a guarantee as one can expect in this realm) - then long term investors and new ones sitting on the fence could help accelerate the demand and approach a penny. even then - they are going to be facing a mountain of resistance from those just looking for a time to get out, aggressive momentum players, and MMs trying it back down with aggressive naked shorting on every sign of weakness. that does not bode well with closing in on two months of trading (let alone several of those weeks being very light due to the holidays).
again - it can get there. but directly would be investors to a timeline and a loose calculation does not instill confidence or provide solid proof that they intend to due their part to reach that target. i provided some raw numbers previously on what it would take, cash per day with PPS staying relatively constant) and did not factor in the holidays at the end of the year.
they can continue to pat themselves on the back for MRVB "wins" but until those translate to "real" gains that investors can independently confirm and they commence aggressive buyback, they continue to lose credibility with long term investors which they will need more than anyone (as foundation) to get the PPS to that target.
simply does not make sense to me why you not only alienate, but actively discourage the one group that provides the strongest springboard to reach a lofty target that is publicly stated and confidently reiterated.
4
1
Trans-Pacific Aerospace (TPAC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...
Continue Reading
Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...
Continue Reading
AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...
Continue Reading
MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...
Continue Reading
Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...
Continue Reading
Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...
Continue Reading
Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...
Continue Reading
Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...
Continue Reading
D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...
Continue Reading
An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...
Continue Reading
Top 5 Most Recently Viewed Articles
Genentech's Itovebi Shows Significant Progress in Cancer Treatment Genentech, a member of the Roche Group (OTCQX: RHHBY), has made headlines with their recent announcement regarding the positive results from the Phase III INAVO120 study focused on Itovebi (inavolisib). This study investigates the combination of Itovebi, palbociclib (Ibrance), and fulvestrant for...
Continue Reading
Understanding the Recent Options Activity of AST SpaceMobile Recent market patterns indicate that some investors are taking a bearish stance on AST SpaceMobile (NASDAQ: ASTS). This noteworthy behavior is significant for retail traders to consider as shifts in investor sentiment can often hint at future market movements. Generally, when large trades appear, it suggests...
Continue Reading
Impressive Growth in Third Quarter Results Foresight Financial Group, Inc., a multi-bank holding company based in Northern Illinois, has announced remarkable financial results for the third quarter. Net income surged by an impressive 33.3%, rising to $3,396,000 from $2,547,000 recorded the previous year. This significant increase is attributable to a decrease in...
Continue Reading
Enhancing Cancer Treatment Through Collaborative Innovation Certara, Inc. (NASDAQ: CERT), headquartered in Radnor, Pennsylvania, is leading the way in model-informed drug development. The company recently shared encouraging results from their partnership with Ichnos Glenmark Innovation (IGI), focusing on improving the dosing strategy for ISB 2001, a promising candidate in...
Continue Reading
Revolutionizing On-the-Go Footwear Solutions In today's fast-paced world, having the right gear at your fingertips is essential. An inventive individual from Silverlake, with a desire to enhance comfort in our daily lives, has brought forth a remarkable idea for a compact spare pair of shoes known as BETTER THAN BAREFOOT (B T B). The goal behind this innovation is simple...
Continue Reading